ANALYSIS OF BUTADIENE, BUTADIENE MONOXIDE, AND BUTADIENE DIOXIDE IN BLOOD BY GAS-CHROMATOGRAPHY GAS-CHROMATOGRAPHY MASS-SPECTROSCOPY

Citation
We. Bechtold et al., ANALYSIS OF BUTADIENE, BUTADIENE MONOXIDE, AND BUTADIENE DIOXIDE IN BLOOD BY GAS-CHROMATOGRAPHY GAS-CHROMATOGRAPHY MASS-SPECTROSCOPY, Chemical research in toxicology, 8(2), 1995, pp. 182-187
Citations number
16
Categorie Soggetti
Toxicology,Chemistry
ISSN journal
0893228X
Volume
8
Issue
2
Year of publication
1995
Pages
182 - 187
Database
ISI
SICI code
0893-228X(1995)8:2<182:AOBBMA>2.0.ZU;2-P
Abstract
A new method was developed to quantify the levels of 1,3-butadiene (BD ), butadiene monoxide (BDO), and butadiene diepoxide (BDO2) in blood. The method was based on vacuum distillation of tissues followed by ana lysis of the distillates using multidimensional GC/MS. Metabolites iso lated from blood by vacuum distillation were condensed into a cold tra p. After warming the traps to room temperature, BD and BDO were sample d from the trap vapor phase. BDO2 was extracted from the codistilled w ater phase using ethyl acetate. Samples were analyzed using a multidim ensional GC system equipped with a custom-built interface. The method was validated by analysis of 0.75-mL aliquots of mouse blood spiked wi th 5.0, 3.4, and 0.55 nmol of BD, BDO, and BDO2, respectively. The rec overies of analytes were 96 +/- 18%, 125 +/- 15%, and 98 +/- 12%, resp ectively (mean +/- SD, n = 6). Kinetic studies indicated no loss of BD O and BDO2 in blood held at room temperature in closed containers for up to 1 h. The method was applied to blood samples from B6C3F(1) mice and Sprague-Dawley rats exposed by inhalation (nose-only) to 100 ppm B D for 4 h. Blood levels of BD and BDO in exposed rats were 4.1 +/- 1.0 and 0.10 +/- 0.06 mu M, respectively (mean +/- SD, n = 6). Levels of BDO2 were below the limits of detection (0.01 nmol/mL). Blood levels o f BD, BDO, and BDO2 in mice exposed to 100 ppm BD for 4 h were 2.9 +/- 1.3, 0.38 +/- 0.14, and 0.33 +/- 0.19 mu M, respectively (mean +/- SD , n = 6). The results for BDO and BDO2 compare favorably with those pr eviously determined by a less specific method at our Institute. Overal l, the results suggest that although both rats and mice have detectabl e levels of BDO in their blood following similar BD exposures, only mi ce have detectable levels of BDO2. This metabolite may therefore be cr itical in explaining the marked species difference in BD toxicity. Fut ure studies will confirm these results over a variety of time points a nd exposure concentrations.